Intestinal mucosal permeability and rheumatological diseases (Q38678806)

5 September 2017

1 reference

title

Intestinal mucosal permeability and rheumatological diseases (English)

1 reference

5 September 2017

Katz KD

1

1 reference

PubMed ID

2670255

5 September 2017

Hollander D

series ordinal

2

1 reference

5 September 2017

1 August 1989

1 reference

Bailliere's clinical rheumatology

5 September 2017

1 reference

5 September 2017

3

1 reference

5 September 2017

2

1 reference

5 September 2017

271-284

1 reference

Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

The infectious etiology of rheumatoid arthritis. New considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

1 reference

7 January 2021

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Histopathology of intestinal inflammation related to reactive arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Crohn's disease: A scanning electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Malabsorption in rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Permeability characteristics of the human small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Crohn's disease--a permeability disorder of the tight junction?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Intestinal permeability and inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Xylose Test: Effect of Aspirin and Indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Permeability of the small intestine to substances of different molecular weight

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Abnormal intestinal permeability to sugars in villous atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Appearance of dextrans and antidextran antibodies in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Diet therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

111Indium-labelled polymorphonuclear leucocyte scans in rheumatoid arthritis--an important clinical cause of false positive results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

PRELIMINARY EVIDENCE FOR GUT INVOLVEMENT IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Effects Of Fasting and Lactovegetarian Diet on Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

THE SURGICAL RELIEF OF INTESTINAL FOCI OF INFECTION IN CASES OF ARTHRITIS DEFORMANS.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Intestinal permeability to different-sized polyethyleneglycols in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Rheumatoid arthritis and the gut

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

Diet in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2889%2980021-4

7 January 2021

10.1016/S0950-3579(89)80021-4

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

2670255